The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease

por Perakakis, Nikolaos, Stefanakis, Konstantinos, Mantzoros, Christos S.
Publicado 2020

Both Elafibranor and Liraglutide Improve NAFLD / NASH but Affect Differentially the Hepatic Lipidome and Metabolome in a Diet-Induced Obese and Biopsy-Confirmed Mouse Model of NASH

por Perakakis, Nikolaos, Stefanakis, Konstantinos, Feigh, Michael, Veidal, Sanne S, Mantzoros, Christos S
Publicado 2021

OR01-5 Leptin Acts through Altering Energy Intake and Lipolysis to Reduce Body Weight but Has No Effect on Energy Expenditure, Physical Activity, and Sympathetic Nervous System in...

por Chrysafi, Pavlina, Peradze, Natia, Stefanakis, Konstantinos, Pilitsi, Eleni, Farr, Olivia, Mantzoros, Christos
Publicado 2019

Leptin alters energy intake and fat mass but not energy expenditure in lean subjects

por Chrysafi, Pavlina, Perakakis, Nikolaos, Farr, Olivia M., Stefanakis, Konstantinos, Peradze, Natia, Sala-Vila, Aleix, Mantzoros, Christos S.
Publicado 2020

The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohep...

por Perakakis, Nikolaos, Joshi, Aditya, Peradze, Natia, Stefanakis, Konstantinos, Li, Georgia, Feigh, Michael, Veidal, Sanne Skovgard, Rosen, Glenn, Fleming, Michael, Mantzoros, Christos S.
Publicado 2020